To create molecules with unique properties, Associate Professor Robert Gilliard and his team deploy strategies from both organic and inorganic chemistry.
Dr. Su was selected by an independent committee of CEOs for her work leading one of the most spectacular turnarounds in the history of the technology sector.
The MIT-led projects will investigate novel high-performance designs, materials, processes, and assessment methods for an environmentally sustainable microchip industry.
Alnylam Pharmaceuticals, founded by MIT professors and former postdocs, has turned the promise of RNAi research into a new class of powerful therapies.